Alpenglow Biosciences and Virdx: Multi-year, milestone-based collaboration to accelerate the development of tools that bridge radiology and pathology. Aims to improve prostate cancer diagnosis and reduce unnecessary interventions. ...

Artera: Novel risk stratification tool advances the frontier of precision oncology by providing access to insights informing critical on-the-ground treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of...

Philips: Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health...

Artera: Clinicians and patients throughout New York State can now access personalized, actionable insights to inform prostate cancer treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal...

March 6, 2025 at 09:30 a.m. EET. The regional health authority of Sardinia in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics. This collaboration involves utilizing Aiforia's clinical AI solutions to analyze...

SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial intelligence (AI)-enabled prognostic and...